Goodwin Procter partner Elizabeth Holland loves the everyday intellectual challenge of problem solving in high-stakes patent litigation featuring Big Pharma. But it is the tense moments inside the courtroom where she often does her most effective work.
In 2015, after nearly a quarter-century of defending branded and generic drug companies successfully, she scored a troika of victories that stood out even by her standards.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
